Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HMGCR | P04035 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | ACLY | P53396 | 3/20 | 0.39 |
| ▸ | CPT2 | P23786 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | MIF | P14174 | 1/20 | 0.34 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.32 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11405967 | 0.97 | ALDH1A1 (0.52) | ALDH1A1CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL20973099 | 0.97 | ALDH1A1 (0.52) | ALDH1A1CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL10797042 | 0.97 | ALDH1A1 (0.52) | ALDH1A1CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL8721139 | 0.97 | ALDH1A1 (0.52) | ALDH1A1CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL330107 | 0.94 | ALDH1A1 (0.50) | ALDH1A1CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL2770806 | 0.94 | ALDH1A1 (0.50) | ALDH1A1CYP2C19HIF1ACYP2D6TSHR | |
| Phosphoric Acid SCHEMBL8917347 | 0.89 | ALDH1A1 (0.46) | ALDH1A1CYP2C19HIF1ACYP2D6TSHR | |
| Inositol SCHEMBL2519274 | 0.89 | ALDH1A1 (0.46) | ALDH1A1CYP2C19HIF1ACYP2D6TSHR | |
| Cadaverine Tartrate SCHEMBL9058804 | 0.85 | TSHR (0.46) | ALDH1A1CYP2C19HIF1ACYP2D6TSHR | |
| Succimer SCHEMBL2511150 | 0.85 | TDP1 (0.50) | ALDH1A1CYP2C19HIF1ACYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6410 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094309-A | Optoelectronic device and method for producing the same | — | 2026-05-26 | — | — | CN | claimed |
| CN-121182437-B | Ultraviolet light curing composition for prismatic film with transverse grain structure and preparation method thereof | 上海绘兰材料科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260130847-A1 | INGESTIBLE IN VIVO-ASSEMBLING DRUG RELEASE FORMULATIONS AND METHODS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-05-14 | — | — | US | claimed |
| EP-4739293-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | AZURA OPHTHALMICS LTD (IL) | 2026-05-13 | — | — | EP | claimed |
| EP-4739291-A2 | ADMINISTRATION OF KERATOLYTICS TO OCULAR AND PERIOCULAR SURFACES | AZURA OPHTHALMICS LTD (IL) | 2026-05-13 | — | — | EP | claimed |
| CN-122016687-A | Silver metallized microbubbles in Hg2+Detection and application of alloy microbubble nano enzyme prepared by detection in detection of reducing drugs | 广西医科大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260077073-A1 | GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-TARGETED COMPOUNDS AND USES THEREOF | ALPHA 9 ONCOLOGY INC (CA) | 2026-03-19 | — | — | US | claimed |
| EP-4042999-B1 | DRUG ACCOMMODATING DEVICE OF SOLID ORAL FORMULATION, AND ORAL ADMINISTRATION AND DELIVERY APPARATUS COMPRISING SAME | SHANGHAI WD PHARMACEUTICAL CO LTD (CN) | 2026-03-04 | — | — | EP | claimed |
| WO-2026041906-A1 | SEMI-SOLID PHARMACEUTICAL COMPOSITION MICRO-DISPENSER | Azura Ophthalmics Ltd. (IL) | 2026-02-26 | — | — | WO | claimed |
| US-20260048156-A1 | FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS | Atoms for Cure GmbH (DE) | 2026-02-19 | — | — | US | claimed |
| WO-1986001410-A1 | ANTIBODY-METAL ION COMPLEXES | CYTOGEN CORPORATION (US) | 1986-03-13 | — | — | WO | claimed |
| EP-0173629-A1 | Antibody-metal ion complexes | CYTOGEN CORPORATION (US) | 1986-03-05 | — | — | EP | claimed |
| WO-1985003063-A1 | PREPARATION OF 99mTC RADIOPHARMACEUTICALS | THE COMMONWEALTH OF AUSTRALIA (AU) | 1985-07-18 | — | — | WO | claimed |
| EP-0133603-A1 | Specific relaxation agents for organs or pathologics for use in modifying the contrast of medical imagery by nuclear magnetic resonance | Société anonyme: COMPAGNIE ORIS INDUSTRIE (FR) | 1985-02-27 | — | — | EP | claimed |
| US-4364920-A | Stable diagnostic reagents | MEDI-PHYSICS, INC. (US) | 1982-12-21 | — | — | US | claimed |
| US-4208398-A | COMPLEXED WITH MERCAPTANS, KIDNEY SPECIFIC | HOFFMAN-LA ROCHE INC. (US) | 1980-06-17 | — | — | US | claimed |
| US-4057615-A | Method of tagging excipients with 99M technetium | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1977-11-08 | — | — | US | claimed |
| US-3995020-A | Radioactive erbium-165 complexes and methods of preparation and use thereof | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 1976-11-30 | — | — | US | claimed |
| US-3984522-A | Method of removing nitrogen monoxide from a nitrogen monoxide-containing gas | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) | 1976-10-05 | — | — | US | claimed |
| US-3943100-A | THIOMALIC, DIMERCAPTOSUCCINIC, GALLIC, CITRIC OR TARTARIC ACID OR SALTS | ALLIED CHEMICAL CORPORATION (US) | 1976-03-09 | — | — | US | claimed |